These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23585412)

  • 21. A study of the haematologic spectrum of myelodysplastic syndrome.
    Kini J; Khadilkar UN; Dayal JP
    Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosupressive treatment with cyclosporin-A for a patient with hypoplastic myelodisplastic syndrome: a case report.
    Pavkovic M; Jovanovic R; Petrusevska G; Cevreska L; Stojanovic A
    Prilozi; 2011; 32(1):313-21. PubMed ID: 21822198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual case of pancytopenia associated with Sheehan's syndrome.
    Gokmen Akoz A; Atmaca H; Ustundag Y; Ozdamar SO
    Ann Hematol; 2007 Apr; 86(4):307-8. PubMed ID: 17203323
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hematological characteristics in primary myelodysplastic syndromes: retrospective study of 14 cases].
    Elloumi M; Frikha M; Haddouk Y; Makni F; Souissi T
    Tunis Med; 1993; 71(6-7):333-8. PubMed ID: 8249207
    [No Abstract]   [Full Text] [Related]  

  • 25. Images in clinical medicine. Apoptosis in myelodysplastic syndromes.
    Lambertenghi Deliliers G; Caneva L
    N Engl J Med; 1999 May; 340(21):1639. PubMed ID: 10341276
    [No Abstract]   [Full Text] [Related]  

  • 26. "Myelodysplasia" from copper deficiency.
    Siddiqui S; Ramlal R
    Blood; 2019 Feb; 133(8):883. PubMed ID: 30792227
    [No Abstract]   [Full Text] [Related]  

  • 27. Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes.
    Invernizzi R; Travaglino E; De Amici M; Brugnatelli S; Ramajoli I; Rovati B; Benatti C; Ascari E
    Leuk Res; 2005 Jun; 29(6):641-7. PubMed ID: 15863203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
    Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
    Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
    Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.
    Buckstein R; Jang K; Friedlich J; Zhang L; Reis M; Chesney A; Wells RA
    Leuk Res; 2009 Oct; 33(10):1313-8. PubMed ID: 19282029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
    Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
    Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of lenalidomide treatment and complete cytogenetic remission in a case of myelodysplastic syndrome with del(5q) and del(9q).
    Xiong B; Liu X; Zou P; Fan L; Chen W; Li W; Liu L
    Leuk Res; 2010 Jul; 34(7):e169-72. PubMed ID: 20122730
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune-induced cytopenia: bone marrow failure syndrome.
    Kondo Y; Molldrem JJ
    Curr Hematol Rep; 2004 May; 3(3):178-83. PubMed ID: 15087065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trial.
    Chung CY; Lin SF; Chen PM; Chang MC; Kao WY; Chao TY; Hsiao LT; Yen CC; Yang MH; Hwang WS; Lin TL; Chiou TJ; Chang CS
    Anticancer Res; 2012 Aug; 32(8):3415-9. PubMed ID: 22843924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes.
    Niscola P; Maurillo L; Palombi M; Fratoni S; Perrotti AP; Piccioni D; Panetta P; Scaramucci L; Del Poeta G; de Fabritiis P
    Acta Haematol; 2007; 118(3):165-6. PubMed ID: 17890850
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of myelodysplastic syndromes with immunosuppressive agents].
    Tohyama K; Ishikawa T
    Rinsho Ketsueki; 2002 Apr; 43(4):261-4. PubMed ID: 12043204
    [No Abstract]   [Full Text] [Related]  

  • 37. Gaucher disease, myelodysplastic syndrome and ICUS.
    Ruchlemer R; Mittelman M; Zimran A
    Blood Cells Mol Dis; 2020 Feb; 80():102373. PubMed ID: 31718920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foamy Plasma Cells in Oligosecretory Multiple Myeloma.
    Ferrara G; Broglia I; Mariani MP
    Int J Surg Pathol; 2021 Jun; 29(4):408-409. PubMed ID: 32419548
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of TP53 mutations in clonal cytopenia of undetermined significance.
    Wang W; Routbort MJ; Ok CY; Patel KP; Sun Y; Kanagal-Shamanna R; Medeiros LJ; Wang SA
    Am J Hematol; 2017 Aug; 92(8):E175-E177. PubMed ID: 28494520
    [No Abstract]   [Full Text] [Related]  

  • 40. Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cells.
    Meers S; Kasran A; Boon L; Lemmens J; Ravoet C; Boogaerts M; Verhoef G; Verfaillie C; Delforge M
    Leukemia; 2007 Dec; 21(12):2411-9. PubMed ID: 17805323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.